Patient Square Capital LP Q1 2025 Filing
Filed May 14, 2025
Portfolio Value
$241.7B
Holdings
19
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (19 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ROIVROIVANT SCIENCES LTD. | 12,480,000 | $125.9B | 52.09% | |
| 2 | IM8NINSMED INC | 330,250 | $25.2B | 10.42% | |
| 3 | LQDALIQUIDIA CORPORATION | 1,522,452 | $22.5B | 9.29% | |
| 4 | EYPTEYEPOINT PHARMACEUTICALS, INC. | 1,481,977 | $8.0B | 3.32% | |
| 5 | OCULOCULAR THERAPEUTIX, INC. | 920,199 | $6.7B | 2.79% | |
| 6 | CGEMCULLINAN THERAPEUTICS, INC. | 878,897 | $6.7B | 2.75% | |
| 7 | NRIXNURIX THERAPEUTICS, INC. | 447,296 | $5.3B | 2.20% | |
| 8 | MIRMMIRUM PHARMACEUTICALS, INC. | 116,362 | $5.2B | 2.17% | |
| 9 | ELVNENLIVEN THERAPEUTICS, INC. | 253,838 | $5.0B | 2.07% | |
| 10 | SRRKSCHOLAR ROCK HOLDING CORPORATION | 154,000 | $5.0B | 2.05% | |
| 11 | IRONDISC MEDICINE, INC. | 83,000 | $4.1B | 1.70% | |
| 12 | AGIOAGIOS PHARMACEUTICALS, INC. | 139,732 | $4.1B | 1.69% | |
| 13 | KYMRKYMERA THERAPEUTICS, INC. | 142,201 | $3.9B | 1.61% | |
| 14 | PHVSPHARVARIS N. V. | 245,496 | $3.9B | 1.59% | |
| 15 | ALLOALLOGENE THERAPEUTICS, INC. | 2,368,186 | $3.5B | 1.43% | |
| 16 | 2L9BLUEPRINT MEDICINES CORPORATION | 38,500 | $3.4B | 1.41% | |
| 17 | NTLAINTELLIA THERAPEUTICS, INC. | 232,781 | $1.7B | 0.68% | |
| 18 | SLNOSOLENO THERAPEUTICS, INC. | 18,600 | $1.3B | 0.55% | |
| 19 | VYNEVYNE THERAPEUTICS INC. | 257,033 | $406.1M | 0.17% |